As of 2026-09-22, the Intrinsic Value of Aldeyra Therapeutics Inc (ALDX) is -1.91 USD. This ALDX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.35 USD, the upside of Aldeyra Therapeutics Inc is -241.55%.
Based on its market price of 1.35 USD and our intrinsic valuation, Aldeyra Therapeutics Inc (ALDX) is overvalued by 241.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.91 - -1.91 | -1.91 | -241.55% |
| P/E | (7.38) - (9.29) | (8.02) | -693.8% |
| DDM - Stable | (3.34) - (11.30) | (7.32) | -642.2% |
| DDM - Multi | (4.49) - (12.03) | (6.56) | -586.2% |
| Market Cap (mil) | 81.43 |
| Beta | 2.69 |
| Outstanding shares (mil) | 60.32 |
| Enterprise Value (mil) | 36.34 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.53% |
| Cost of Debt | 5.00% |
| WACC | 8.68% |